1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Epigenetics Market by Product, by Research Area - Global Forecast to 2020

The epigenetics market is expected to reach USD 890.0 million by 2020 from USD 469.6 million in 2015, at a CAGR of 13.64% between 2015 and 2020. By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further subsegmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. The kits segment is expected to grow at the highest rate. Based on research areas, the market is segmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share in the global epigenetics market in 2015. Asia is expected to register the fastest growth.

Market growth is majorly driven by the high prevalence of cancer, increasing R & D funding and increasing intensity of genomic research activities. Other growth factors include increasing application for non-oncology diseases and growing partnership between academic, biotechnology and pharmaceutical companies

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global epigenetics market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development: Product portfolios of the top players in the epigenetics market.
- Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the epigenetics market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various epigenetics products and services across geographies.

Table Of Contents

Epigenetics Market by Product, by Research Area - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.3 MARKET SHARE ESTIMATION 24
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 25
2.3.3 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 29
4.1 GLOBAL EPIGENETICS MARKET OVERVIEW 29
4.2 LIFE CYCLE ANALYSIS, BY REGION 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET SEGMENTATION 32
5.2.1 EPIGENETICS MARKET SEGMENTATION: BY PRODUCT 32
5.2.2 EPIGENETICS MARKET SEGMENTATION: BY RESEARCH AREA 32
5.3 MARKET DYNAMICS 33
5.3.1 DRIVERS 34
5.3.1.1 High prevalence of cancer 34
5.3.1.2 Growing funding for epigenetics-based research 34
5.3.1.3 Increasing intensity of research activities in the field of epigenetics 34
5.3.1.4 Growing application of epigenetics in non-oncology diseases 35
5.3.1.5 Growth in the number of partnerships between academic institutes and biotechnology and pharmaceutical companies for epigenetic-based products 35

5.3.2 RESTRAINTS 36
5.3.2.1 High cost of instruments 36
5.3.2.2 Lack of trained professionals 36
5.3.3 OPPORTUNITIES 36
5.3.3.1 Emerging markets to present significant growth opportunities 36
6 EPIGENETICS MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 ENZYMES 40
6.2.1 DNA-MODIFYING ENZYMES 43
6.2.2 PROTEIN-MODIFYING ENZYMES 44
6.2.3 RNA-MODIFYING ENZYMES 46
6.3 INSTRUMENTS AND CONSUMABLES 48
6.3.1 MASS SPECTROMETERS 51
6.3.2 NEXT-GENERATION SEQUENCERS 52
6.3.3 QPCR 53
6.3.4 SONICATORS 54
6.3.5 OTHER EPIGENETICS INSTRUMENTS AND CONSUMABLES 55
6.4 KITS 56
6.4.1 BISULFITE CONVERSION KITS 59
6.4.2 CHIP-SEQ KITS 60
6.4.3 RNA SEQUENCING KITS 61
6.4.4 WHOLE-GENOME AMPLIFICATION KITS 62
6.4.5 5-HMC AND 5-MC ANALYSIS KITS 63
6.4.6 OTHER EPIGENETICS KITS 64
6.5 REAGENTS 65
6.5.1 ANTIBODIES 67
6.5.2 BUFFERS 68
6.5.3 HISTONES 69
6.5.4 MAGNETIC BEADS 70
6.5.5 PRIMERS 71
6.5.6 OTHER EPIGENETICS REAGENTS 72
7 EPIGENETICS MARKET, BY RESEARCH AREA 73
7.1 INTRODUCTION 74
7.2 DEVELOPMENTAL BIOLOGY 76
7.3 DRUG DISCOVERY 77
7.4 ONCOLOGY 78
7.5 OTHER RESEARCH AREAS 80

8 EPIGENETICS MARKET, BY REGION 82
8.1 INTRODUCTION 83
8.2 NORTH AMERICA 86
8.2.1 U.S. 93
8.2.2 CANADA 97
8.3 EUROPE 102
8.4 ASIA 107
8.5 REST OF THE WORLD (ROW) 113
9 COMPETITIVE LANDSCAPE 118
9.1 INTRODUCTION 118
9.2 STRATEGIC OVERVIEW 118
9.3 LEADING PLAYERS IN THE EPIGENETICS MARKET 119
9.4 COMPETITIVE SITUATION AND TRENDS 120
9.4.1 NEW PRODUCT AND SERVICE LAUNCHES 121
9.4.2 AGREEMENTS, ALLIANCES, COLLABORATIONS, AND PARTNERSHIPS 122
9.4.3 ACQUISITIONS 123
9.4.4 EXPANSIONS 124
9.4.5 OTHER DEVELOPMENTS 125
10 COMPANY PROFILES 126
(Overview, Financials, Products and Services, Strategy, and Developments)*
10.1 INTRODUCTION 126
10.2 ABCAM PLC 127
10.3 ACTIVE MOTIF 131
10.4 DIAGENODE, INC. 133
10.5 ILLUMINA, INC. 135
10.6 MERCK and CO., INC. 138
10.7 NEW ENGLAND BIOLABS 141
10.8 QIAGEN N.V. 143
10.9 SIGMA-ALDRICH CORPORATION 146
10.10 THERMO FISHER SCIENTIFIC, INC. 149
10.11 ZYMO RESEARCH CORPORATION 153
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.


11 APPENDIX 155
11.1 INSIGHTS OF INDUSTRY EXPERTS 155
11.2 DISCUSSION GUIDE 156
11.3 OTHER DEVELOPMENTS 158
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 164
11.5 AVAILABLE CUSTOMIZATIONS 165
11.6 RELATED REPORTS 166


LIST OF TABLES

TABLE 1 EPIGENETICS MARKET SNAPSHOT 26
TABLE 2 HIGH PREVALENCE OF CANCER IS A MAJOR FACTOR DRIVING MARKET GROWTH 35
TABLE 3 HIGH COST OF INSTRUMENTS TO RESTRAIN MARKET GROWTH 36
TABLE 4 EMERGING ECONOMIES EXPECTED TO OFFER GROWTH OPPORTUNITIES IN THE COMING YEARS 37
TABLE 5 EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION) 40
TABLE 6 EPIGENETICS ENZYMES MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION) 41
TABLE 7 EPIGENETICS ENZYMES MARKET SIZE, BY REGION, 2012-2020 (USD MILLION) 42
TABLE 8 EPIGENETICS MARKET SIZE FOR DNA-MODIFYING ENZYMES, BY TYPE,
2012-2020 (USD MILLION) 43
TABLE 9 EPIGENETICS MARKET SIZE FOR DNA-MODIFYING ENZYMES, BY REGION,
2012-2020 (USD MILLION) 44
TABLE 10 EPIGENETICS MARKET SIZE FOR PROTEIN-MODIFYING ENZYMES, BY TYPE,
2012-2020 (USD MILLION) 45
TABLE 11 EPIGENETICS MARKET SIZE FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2012-2020 (USD MILLION) 45
TABLE 12 EPIGENETICS MARKET SIZE FOR RNA-MODIFYING ENZYMES, BY TYPE,
2012-2020 (USD MILLION) 47
TABLE 13 EPIGENETICS MARKET SIZE FOR RNA-MODIFYING ENZYMES, BY REGION,
2012-2020 (USD MILLION) 47
TABLE 14 EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET SIZE, BY TYPE,
2012-2020 (USD MILLION) 49
TABLE 15 EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2012-2020 (USD MILLION) 50
TABLE 16 EPIGENETICS MARKET SIZE FOR MASS SPECTROMETERS, BY REGION,
2012-2020 (USD MILLION) 51
TABLE 17 EPIGENETICS MARKET SIZE FOR NEXT-GENERATION SEQUENCERS, BY REGION, 2012-2020 (USD MILLION) 52
TABLE 18 EPIGENETICS MARKET SIZE FOR QPCR, BY REGION, 2012-2020 (USD MILLION) 53
TABLE 19 EPIGENETICS MARKET SIZE FOR SONICATORS, BY REGION,
2012-2020 (USD MILLION) 54
TABLE 20 EPIGENETICS MARKET SIZE FOR OTHER INSTRUMENTS AND CONSUMABLES,
BY REGION, 2012-2020 (USD MILLION) 55
TABLE 21 EPIGENETICS KITS MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION) 57
TABLE 22 EPIGENETICS KITS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION) 58
TABLE 23 EPIGENETICS MARKET SIZE FOR BISULFITE CONVERSION KITS, BY REGION,
2012-2020 (USD MILLION) 59
TABLE 24 EPIGENETICS MARKET SIZE FOR CHIP-SEQ KITS, BY REGION,
2012-2020 (USD MILLION) 60
TABLE 25 EPIGENETICS MARKET SIZE FOR RNA SEQUENCING KITS, BY REGION,
2012-2020 (USD MILLION) 61
TABLE 26 EPIGENETICS MARKET SIZE FOR WHOLE-GENOME AMPLIFICATION KITS,
BY REGION, 2012-2020 (USD MILLION) 62
TABLE 27 EPIGENETICS MARKET SIZE FOR 5-HMC AND 5-MC ANALYSIS KITS, BY REGION, 2012-2020 (USD MILLION) 63
TABLE 28 OTHER EPIGENETICS KITS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION) 64
TABLE 29 EPIGENETICS REAGENTS MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION) 66
TABLE 30 EPIGENETICS REAGENTS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION) 67
TABLE 31 EPIGENETICS MARKET SIZE FOR ANTIBODIES, BY REGION,
2012-2020 (USD MILLION) 67
TABLE 32 EPIGENETICS MARKET SIZE FOR BUFFERS, BY REGION,
2012-2020 (USD MILLION) 68
TABLE 33 EPIGENETICS MARKET SIZE FOR HISTONES, BY REGION,
2012-2020 (USD MILLION) 69
TABLE 34 EPIGENETICS MARKET SIZE FOR MAGNETIC BEADS, BY REGION,
2012-2020 (USD MILLION) 70
TABLE 35 EPIGENETICS MARKET SIZE FOR PRIMERS, BY REGION,
2012-2020 (USD MILLION) 71
TABLE 36 OTHER EPIGENETICS REAGENTS MARKET SIZE, BY REGION,
2012-2020 (USD MILLION) 72
TABLE 37 EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION) 75
TABLE 38 EPIGENETICS MARKET SIZE FOR DEVELOPMENTAL BIOLOGY, BY REGION,
2012-2020 (USD MILLION) 76
TABLE 39 EPIGENETICS MARKET SIZE FOR DRUG DISCOVERY, BY REGION,
2012-2020 (USD MILLION) 78
TABLE 40 EPIGENETICS MARKET SIZE FOR ONCOLOGY, BY REGION,
2012-2020 (USD MILLION) 79
TABLE 41 EPIGENETICS MARKET SIZE FOR OTHER RESEARCH AREAS, BY REGION,
2012-2020 (USD MILLION) 81
TABLE 42 EPIGENETICS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION) 84
TABLE 43 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY COUNTRY,
2012-2020 (USD MILLION) 88
TABLE 44 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY PRODUCT,
2012-2020 (USD MILLION) 89
TABLE 45 NORTH AMERICA: EPIGENETICS ENZYME MARKET SIZE, BY TYPE,
2012-2020 (USD MILLION) 90
TABLE 46 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION) 91
TABLE 47 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA,
2012-2020 (USD MILLION) 92
TABLE 48 U.S.: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION) 94
TABLE 49 U.S.: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION) 95
TABLE 50 U.S.: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE,
2012-2020 (USD MILLION) 96
TABLE 51 U.S.: EPIGENETICS MARKET SIZE, BY RESEARCH AREA,
2012-2020 (USD MILLION) 97
TABLE 52 CANADA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION) 98
TABLE 53 CANADA: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION) 99
TABLE 54 CANADA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE,
2012-2020 (USD MILLION) 100
TABLE 55 CANADA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA,
2012-2020 (USD MILLION) 101
TABLE 56 EUROPE: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION) 103
TABLE 57 EUROPE: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION) 104
TABLE 58 EUROPE: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE,
2012-2020 (USD MILLION) 105
TABLE 59 EUROPE: EPIGENETICS MARKET SIZE, BY RESEARCH AREA,
2012-2020 (USD MILLION) 106
TABLE 60 ASIA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION) 109
TABLE 61 ASIA: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION) 110
TABLE 62 ASIA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE,
2012-2020 (USD MILLION) 111
TABLE 63 ASIA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA,
2012-2020 (USD MILLION) 112
TABLE 64 ROW: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION) 114
TABLE 65 ROW: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION) 115
TABLE 66 ROW: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE,
2012-2020 (USD MILLION) 116
TABLE 67 ROW: EPIGENETICS MARKET SIZE, BY RESEARCH AREA,
2012-2020 (USD MILLION) 117
TABLE 68 RANK OF COMPANIES IN THE GLOBAL EPIGENETICS MARKET, 2015 119
TABLE 69 MARKET DEVELOPMENTS, 2011-2015 120
TABLE 70 NEW PRODUCT AND SERVICE LAUNCHES , 2011-2015 121
TABLE 71 AGREEMENTS, ALLIANCES, COLLABORATIONS, AND PARTNERSHIPS , 2011-2015 122
TABLE 72 ACQUISITIONS, 2011-2015 123
TABLE 73 EXPANSIONS, 2011-2015 124
TABLE 74 OTHER DEVELOPMENTS, 2011-2015 125
TABLE 75 LIST OF DEVELOPMENTS FOR ABCAM PLC, 2011-2015 130
TABLE 76 LIST OF DEVELOPMENTS FOR ACTIVE MOTIF, 2011-2015 132
TABLE 77 LIST OF DEVELOPMENTS FOR DIAGENODE, INC., 2011-2015 134
TABLE 78 LIST OF DEVELOPMENTS FOR ILLUMINA, INC., 2011-2015 137
TABLE 79 LIST OF DEVELOPMENTS FOR MERCK and CO., INC., 2011-2015 140
TABLE 80 LIST OF DEVELOPMENTS FOR NEW ENGLAND BIOLABS, 2011-2015 142
TABLE 81 LIST OF DEVELOPMENTS FOR QIAGEN N.V., 2011-2015 145
TABLE 82 LIST OF DEVELOPMENTS FOR SIGMA-ALDRICH CORPORATION, 2011-2015 148
TABLE 83 LIST OF DEVELOPMENTS FOR THERMO FISHER SCIENTIFIC, INC., 2011-2015 152
TABLE 84 LIST OF DEVELOPMENTS FOR ZYMO RESEARCH CORPORATION, 2011-2015 154


LIST OF FIGURES

FIGURE 1 EPIGENETICS MARKET 17
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 EPIGENETICS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 27
FIGURE 8 EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2015 VS. 2020 (USD MILLION) 27
FIGURE 9 EPIGENETICS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 28
FIGURE 10 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 29
FIGURE 11 ONCOLOGY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 30
FIGURE 12 ASIA TO GROW AT THE HIGHEST RATE IN THE FORECAST PERIOD (2015-2020) 30
FIGURE 13 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 31
FIGURE 14 EPIGENETICS MARKET: BY PRODUCT 32
FIGURE 15 EPIGENETICS MARKET: BY RESEARCH AREA 32
FIGURE 16 EPIGENETICS MARKET: DRIVERS, RESTRAINTS, and OPPORTUNITIES 33
FIGURE 17 EPIGENETICS MARKET SEGMENTATION, BY PRODUCT 39
FIGURE 18 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2015 39
FIGURE 19 EPIGENETICS ENZYMES MARKET SEGMENTATION, BY TYPE 40
FIGURE 20 DNA-MODIFYING ENZYMES TO DOMINATE THE EPIGENETICS ENZYMES MARKET
IN 2015 41
FIGURE 21 NORTH AMERICA TO FORM THE LARGEST REGIONAL SEGMENT OF THE EPIGENETICS ENZYMES MARKET 42
FIGURE 22 DNA-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE 43
FIGURE 23 PROTEIN-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE 44
FIGURE 24 RNA-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE 46
FIGURE 25 EPIGENETICS INSTRUMENTS and CONSUMABLES MARKET, BY TYPE 48
FIGURE 26 NEXT-GENERATION SEQUENCERS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET IN 2015 49
FIGURE 27 ASIA—THE FASTEST-GROWING REGIONAL MARKET FOR EPIGENETICS INSTRUMENTS AND CONSUMABLES BETWEEN 2015 AND 2020 50
FIGURE 28 EPIGENETICS KITS MARKET SEGMENTATION, BY TYPE 56
FIGURE 29 CHIP-SEQ KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS KITS MARKET IN 2015 57
FIGURE 30 ASIA TO FORM THE FASTEST-GROWING REGIONAL MARKET FOR EPIGENETICS KITS 58
FIGURE 31 EPIGENETICS REAGENTS MARKET SEGMENTATION, BY TYPE 65
FIGURE 32 ANTIBODIES TO FORM THE LARGEST SEGMENT OF THE EPIGENETICS REAGENTS MARKET IN 2020 65
FIGURE 33 NORTH AMERICA HOLDS THE LARGEST SHARE FOR THE EPIGENETICS REAGENTS MARKET BETWEEN 2015 AND 2020 66
FIGURE 34 EPIGENETICS MARKET SEGMENTATION, BY RESEARCH AREA 74
FIGURE 35 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN 2015 75
FIGURE 36 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY 76
FIGURE 37 NORTH AMERICA EXPECTED TO DOMINATE THE EPIGENETICS MARKET FOR DRUG DISCOVERY DURING THE FORECAST PERIOD 77
FIGURE 38 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET FOR ONCOLOGY 79
FIGURE 39 NORTH AMERICA TO FORM THE LARGEST REGIONAL SEGMENT OF THE OTHER EPIGENETICS RESEARCH AREAS MARKET 81
FIGURE 40 GLOBAL: ECONOMIC INDICATORS 83
FIGURE 41 EPIGENETICS MARKET SEGMENTATION, BY REGION 83
FIGURE 42 ASIA TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD 84
FIGURE 43 EPIGENETICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020 85
FIGURE 44 NORTH AMERICA: ECONOMIC INDICATORS 86
FIGURE 45 NORTH AMERICA: MARKET SNAPSHOT 87
FIGURE 46 U.S. FORMS THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015 88
FIGURE 47 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN NORTH AMERICA IN 2015 89
FIGURE 48 DNA-MODIFYING ENZYMES SEGMENT DOMINATES THE ENZYME MARKET IN NORTH AMERICA IN 2015 90
FIGURE 49 NEXT-GENERATION SEQUENCERS SEGMENT HOLDS LARGEST SHARE IN THE NORTH AMERICAN INSTRUMENTS AND CONSUMABLES MARKET IN 2015 91
FIGURE 50 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN NORTH AMERICA IN 2015 92
FIGURE 51 KITS COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN THE U.S. IN 2015 93
FIGURE 52 DNA-MODIFYING ENZYMES TO COMMAND THE LARGEST SHARE IN THE EPIGENETICS ENZYME MARKET IN THE U.S. IN 2015 94
FIGURE 53 NEXT-GENERATION SEQUENCERS TO ACCOUNT FOR THE LARGEST SHARE IN THE EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET IN THE U.S. IN 2015 95
FIGURE 54 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN THE U.S.
IN 2015 96
FIGURE 55 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN CANADA IN 2015 98
FIGURE 56 DNA-MODIFYING ENZYMES TO COMMAND THE LARGEST SHARE IN THE EPIGENETICS ENZYME MARKET IN CANADA IN 2015 99
FIGURE 57 NEXT-GENERATION SEQUENCERS TO ACCOUNT FOR THE LARGEST SHARE IN THE CANADIAN INSTRUMENTS AND CONSUMABLES MARKET IN 2015 100
FIGURE 58 ONCOLOGY FORMS THE LARGEST RESEARCH AREAS SEGMENT IN CANADA
IN 2015 101
FIGURE 59 EUROPE: ECONOMIC INDICATORS 102
FIGURE 60 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN EUROPE IN 2015 103
FIGURE 61 DNA-MODIFYING ENZYMES SEGMENT TO COMMAND THE LARGEST SHARE IN THE EUROPEAN ENZYME MARKET IN 2015 104
FIGURE 62 NEXT-GENERATION SEQUENCERS SEGMENT HOLDS THE LARGEST SHARE IN THE EUROPEAN INSTRUMENTS AND CONSUMABLES MARKET (2015) 105
FIGURE 63 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN EUROPE
IN 2015 106
FIGURE 64 ASIA: ECONOMIC INDICATORS 107
FIGURE 65 ASIA: MARKET SNAPSHOT 108
FIGURE 66 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN ASIA
IN 2015 109
FIGURE 67 DNA-MODIFYING ENZYMES SEGMENT DOMINATES THE ASIAN MARKET IN 2015 110
FIGURE 68 NEXT-GENERATION SEQUENCERS TO HOLD THE LARGEST MARKET SHARE IN THE ASIAN INSTRUMENTS AND CONSUMABLES MARKET, IN 2015 111
FIGURE 69 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN ASIA IN 2015 112
FIGURE 70 REST OF THE WORLD: ECONOMIC INDICATORS 113
FIGURE 71 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN ROW IN 2015 114
FIGURE 72 DNA-MODIFYING ENZYMES WILL DOMINATE ROW MARKET IN 2015 115
FIGURE 73 NEXT-GENERATION SEQUENCERS TO FORM THE LARGEST INSTRUMENT AND CONSUMABLE SEGMENT OF THE ROW MARKET 116
FIGURE 74 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN ROW IN 2015 117
FIGURE 75 NEW PRODUCT LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE EPIGENETICS MARKET 118
FIGURE 76 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 126
FIGURE 77 ABCAM PLC: COMPANY SNAPSHOT 127
FIGURE 78 ILLUMINA, INC.: COMPANY SNAPSHOT 135
FIGURE 79 MERCK and CO., INC.: COMPANY SNAPSHOT 138
FIGURE 80 QIAGEN N.V.: COMPANY SNAPSHOT 143
FIGURE 81 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 146
FIGURE 82 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 149

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global Food Enzyme Market

Global Food Enzyme Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The growing demand for processed foods and increasing health consciousness in the people is driving the food & beverages industry which inturn is driving the food enzymes market. Food enzymes are a majo ...

Global and Chinese Enzyme-labeled instrument Industry, 2016 Market Research Report

Global and Chinese Enzyme-labeled instrument Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Enzyme-labeled instrument Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Enzyme-labeled instrument industry ...

Global and Chinese Digestive Health Enzymes Industry, 2016 Market Research Report

Global and Chinese Digestive Health Enzymes Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Digestive Health Enzymes Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Digestive Health Enzymes industry ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.